In addition, we demonstrate a panel of five subtype featured gene signatures (CLUL1, CNGB1, ROM1, LRRC39 and RDH12) have predictive capacity of RB progression with outstanding accuracy. This evidence concerns the gene ROM1 and retinoblastoma.